139 related articles for article (PubMed ID: 18269596)
1. Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial.
Veraldi S; Menter A; Innocenti M
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):290-6. PubMed ID: 18269596
[TBL] [Abstract][Full Text] [Related]
2. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
Elewski B
Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
Feldman SR; Matheson R; Bruce S; Grande K; Markowitz O; Kempers S; Brundage T; Wyres M;
Am J Clin Dermatol; 2012 Aug; 13(4):261-71. PubMed ID: 22587791
[TBL] [Abstract][Full Text] [Related]
4. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
[TBL] [Abstract][Full Text] [Related]
5. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
Seckin D; Gurbuz O; Akin O
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study.
Braza TJ; DiCarlo JB; Soon SL; McCall CO
Br J Dermatol; 2003 Jun; 148(6):1242-4. PubMed ID: 12828755
[TBL] [Abstract][Full Text] [Related]
7. Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial.
Kim TW; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim MB; Song KH; Lee SK; Seo JK; Lee D; Kim BS
Acta Derm Venereol; 2013 Sep; 93(5):557-61. PubMed ID: 23388687
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Zirwas MJ; Draelos ZD; DuBois J; Kircik LH; Moore AY; Stein Gold L; Alonso-Llamazares J; Bukhalo M; Bruce S; Eads K; Green LJ; Guenthner ST; Ferris LK; Forman SB; Kempers SE; Lain E; Lynde CW; Pariser DM; Toth DP; Yamauchi PS; Higham RC; Krupa D; Burnett P; Berk DR
JAMA Dermatol; 2023 Jun; 159(6):613-620. PubMed ID: 37133856
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled pilot study to estimate the efficacy and tolerability of a nonsteroidal cream for the treatment of cradle cap (seborrheic dermatitis).
David E; Tanuos H; Sullivan T; Yan A; Kircik LH
J Drugs Dermatol; 2013 Apr; 12(4):448-52. PubMed ID: 23652893
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits W; Boguniewicz M;
J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
[TBL] [Abstract][Full Text] [Related]
11. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
[TBL] [Abstract][Full Text] [Related]
12. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
13. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
Chosidow O; Maurette C; Dupuy P
Dermatology; 2003; 206(3):233-40. PubMed ID: 12673081
[TBL] [Abstract][Full Text] [Related]
14. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
[TBL] [Abstract][Full Text] [Related]
15. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
[TBL] [Abstract][Full Text] [Related]
16. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
Cicek D; Kandi B; Bakar S; Turgut D
J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
[TBL] [Abstract][Full Text] [Related]
17. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
19. Ciclopirox gel for seborrheic dermatitis of the scalp.
Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
[TBL] [Abstract][Full Text] [Related]
20. Double blind clinical trial in a series of 115 patients with seborrheic dermatitis: prevention of relapses using a topical modulator of Toll like receptor 2.
Ionescu MA; Baroni A; Brambilla L; Cannavò SP; Cristaudo A; Vedove CD; Frasca M; Girolomoni G; Gnecchi L; Peris K; Trifirò C; Matta AM; Robert G
G Ital Dermatol Venereol; 2011 Jun; 146(3):185-9. PubMed ID: 21566548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
